DK43890D0 - Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse - Google Patents

Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse

Info

Publication number
DK43890D0
DK43890D0 DK043890A DK43890A DK43890D0 DK 43890 D0 DK43890 D0 DK 43890D0 DK 043890 A DK043890 A DK 043890A DK 43890 A DK43890 A DK 43890A DK 43890 D0 DK43890 D0 DK 43890D0
Authority
DK
Denmark
Prior art keywords
nucleic acid
vectors
cells containing
produced products
peptides
Prior art date
Application number
DK043890A
Other languages
Danish (da)
English (en)
Other versions
DK43890A (da
Inventor
Raymond Alan Brian Ezekowitz
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22206319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK43890(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of DK43890A publication Critical patent/DK43890A/da
Publication of DK43890D0 publication Critical patent/DK43890D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK043890A 1987-08-20 1990-02-19 Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse DK43890D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8762887A 1987-08-20 1987-08-20
PCT/US1988/002591 WO1989001519A1 (en) 1987-08-20 1988-08-05 Human mannose binding protein

Publications (2)

Publication Number Publication Date
DK43890A DK43890A (da) 1990-02-19
DK43890D0 true DK43890D0 (da) 1990-02-19

Family

ID=22206319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK043890A DK43890D0 (da) 1987-08-20 1990-02-19 Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse

Country Status (7)

Country Link
EP (1) EP0375736B1 (de)
JP (1) JP2868777B2 (de)
AT (1) ATE165980T1 (de)
DE (1) DE3856180T2 (de)
DK (1) DK43890D0 (de)
FI (1) FI900808A7 (de)
WO (1) WO1989001519A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006010A1 (en) * 1989-10-11 1991-05-02 Institute Of Child Health Diagnostic procedure
GB9023907D0 (en) * 1990-11-02 1990-12-12 Mallucci Livio Cell growth inhibitors
EP0568539A4 (en) * 1990-11-06 1994-07-06 Childrens Medical Center Soluble mannose receptor peptides
CA2056118A1 (en) * 1990-12-24 1992-06-25 Kendra B. Eager Monoclonal antibodies which bind mannose binding protein
DK0598719T3 (da) * 1991-07-31 1999-06-14 Antex Biolog Inc Receptorkonjugater til destinering af lægemidler og andre midler
AU6623096A (en) 1995-07-27 1997-02-26 Imperial College Of Science, Technology And Medicine Methods of predicting the outcome of infection
WO1999010001A1 (en) * 1997-08-21 1999-03-04 Takara Shuzo Co., Ltd. Carcinostatic agents
US7049099B2 (en) 1998-01-23 2006-05-23 Fuso Pharmaceutical Industries, Ltd. Recombinant human mannan-binding proteins and producing method of the same
JP3878737B2 (ja) 1998-01-23 2007-02-07 扶桑薬品工業株式会社 新規コレクチン
JPH11206378A (ja) 1998-01-23 1999-08-03 Fuso Pharmaceutical Industries Ltd 組換えヒトマンナン結合タンパク質およびその製造方法
US6429192B1 (en) * 1998-06-10 2002-08-06 Statens Serum Institut Purification process for production of mannan-binding lectin and an MBL medicinal product
CA2347734A1 (en) * 1998-12-15 2000-06-22 Brigham And Women's Hospital, Inc. Methods and products for regulating lectin complement pathway associated complement activation
US7273925B1 (en) 1998-12-15 2007-09-25 Brigham And Women's Hospital, Inc. Methods and products for regulating lectin complement pathway associated complement activation
CA2372128A1 (en) * 1999-05-14 2000-11-23 Steffen Thiel Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
CN1899603B (zh) * 1999-05-14 2010-09-08 斯蒂芬·蒂尔 甘露聚糖-结合型凝集素(mbl)在免疫受损个体的治疗中的新意义
EP1262546B1 (de) 2000-02-14 2009-09-02 Fuso Pharmaceutical Industries Ltd. Scavenger-rezeptoren
DK1283214T3 (da) 2000-04-21 2007-06-11 Fuso Pharmaceutical Ind Hidtil ukendte kollektiner
ATE434661T1 (de) * 2000-07-13 2009-07-15 Helion Biotech Aps Masp-2, ein komplement fixierendes enzym, und dessen verwendungen
EP1186299A1 (de) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht Diagnose, Verbeugung und/oder Behandlung von Atherosklerose, Infectionen und Störungen des Immunsystems
WO2007085057A1 (en) * 2006-01-25 2007-08-02 The Council Of The Queensland Institute Of Medical Research A medical protocol
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
ES2678143T3 (es) 2010-01-19 2018-08-09 President And Fellows Of Harvard College Opsonina obtenida por ingeniería genética para la detección y el tratamiento de microorganismos patógenos
EP2734843A2 (de) 2011-07-18 2014-05-28 President and Fellows of Harvard College Manipulierte moleküle zur anzielung von mikroben und ihre verwendungen
AU2013225823A1 (en) 2012-02-29 2014-09-18 President And Fellows Of Harvard College Rapid antibiotic susceptibility testing
EP2976642A4 (de) 2013-03-15 2016-09-21 Harvard College Verfahren und zusammensetzungen zur verbesserung der erkennung und/oder aufnahme einer zieleinheit
US9988617B2 (en) 2013-05-21 2018-06-05 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3546474B1 (de) 2013-12-18 2021-07-07 President and Fellows of Harvard College Crp-erfassung/-detektion von grampositiven bakterien
CN108289928B (zh) 2015-08-06 2024-09-17 哈佛大学校长及研究员协会 改进的微生物-结合分子和其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES522315A0 (es) * 1982-05-12 1984-08-16 Harvard College Un procedimiento para obtener una proteina hibrida.

Also Published As

Publication number Publication date
EP0375736B1 (de) 1998-05-13
EP0375736A1 (de) 1990-07-04
JP2868777B2 (ja) 1999-03-10
FI900808A0 (fi) 1990-02-19
DE3856180T2 (de) 1998-09-03
JPH02504581A (ja) 1990-12-27
DK43890A (da) 1990-02-19
FI900808A7 (fi) 1990-02-19
WO1989001519A1 (en) 1989-02-23
ATE165980T1 (de) 1998-05-15
DE3856180D1 (de) 1998-06-18

Similar Documents

Publication Publication Date Title
DK43890A (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
DK382786D0 (da) Overfladeaktivt rekombinant-alveolarprotein
HUP0003533A2 (hu) Interleukin-18-at kötő fehérjék, előállításuk és alkalmazásuk
DE3751470D1 (de) Pentigetide zur Behandlung von nicht-IgE-vermittelten entzündlichen Erkrankungen.
DE3683482D1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
DE68929551D1 (de) Menschliche DNase
ATE132197T1 (de) Monoklonale antikörper
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
DK0784703T3 (da) Lamininkæder: Diagnostisk og terapeutisk anvendelse
NO960309L (no) Agonister og antagonister for humaninterleukin-10
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
FI913818A0 (fi) Nytt trombolytiskt aemne.
ATE116368T1 (de) Vektoren und verbindungen zur expression von zymogen-formen von menschlichem protein c.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
SE9002212D0 (sv) Igg binding protein
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
BG101846A (bg) Варианти на човешка дезоксирибонуклеаза i
DE3765916D1 (de) Sonde zur einfuehrung in den verdauungs- oder ausscheidungstrakt des menschlichen oder tierischen koerpers, insbesondere lithotriptor-sonde.
NO900745L (no) Humant mannose-bindende protein.
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
NO880825D0 (no) Dietetisk styrke- og helbredelsesmiddel for behandling av den helhetlige organismen hos mennesker og dyr.
ATE223227T1 (de) Verwendung von lbp zur sepsistherapie
DK694287A (da) Overfladeaktivt rekombinant-alveolaerprotein

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment